[ad_1]
Suara.com – Female cancers, including bad, cervical and ovarian cancers, are not only expensive, but can also result in death due to its complications. Dr. Nurlina Subair, MSi, representative of the Women's Cancer Advocacy Association (A2KPI), said that, combined, the number of cases of bad, cervical and ovarian cancer accounted for about 27 % of total number of cancers in Indonesia.
"This creates a dilemma in access to cancer management systems for women, where, in terms of high funding for treatment, the current system does not translate into the right of patients to obtain quality services for cancer management, "said Nurlina. meeting with the media on Thursday (11/08/2018).
Globocan 2018 data report the highest incidence of bad cancer among Indonesian women diagnosed with cancer (about 42.1%) and the second leading cause of death worldwide.
The high rate of women with cancer is the main reason for continuing to call for the importance of strengthening health policies and systems in Indonesia.
"As a" pillar of the state ", the burden of women with cancer is not light.In addition to having to badume their role as a woman, they must also fight against the disease, which is often faced with the lack of access to correct information about cancer, "he added.
For this reason, A2KPI stated that Nurlina had supported the "Treatment for All" campaign launched by the International Union for the Fight Against Cancer (UICC), an international organization of more than 1,000 cancer organizations in the world. the world and focused on cancer control programs.
Teacher. DR. dr. Aru W. Sudoyo, SpPD-KHOM, FACP as President of the Indonesian Cancer Foundation and the Indonesian Association of Oncology, added that this campaign aimed to reduce the number of premature deaths from cancer, with reference to the four main pillars: improving cancer data for public health needs, access to early detection and diagnosis, prompt and accurate care management, palliative services and support services.
"We hope that all treatments will allow cancer patients to access diagnosis and services equally and equitably," said Professor Aru.
[ad_2]
Source link
